TRXC News and Press, TransEnterix Inc. From 09/11/19

Society of Laparoendoscopic Surgeons Recognizes Advanced Technology TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the company’s Senhance ...

With free cash flow of -$39.7 million in the first six months of 2019 and $23 million in cash, TransEnterix ( TRXC ) is selling assets to obtain some money. As a result, the share price is declining at a fast pace. The market appears to be quite worried about the stock dilution risk. Also, t...

Factors Driving Medical Robotic Growth Medical robotics is an emerging sector that has established a solid foundation and continues to grow. According to the Journal of Minimal Access Surgery , "the era of robots in surgery commenced in 1994 when the first AESOP (voice controlled camera hol...

TransEnterix ( TRXC -17.6% ) is down on below-average volume in response to its public offering of 28M common shares that it expects to generate ~$20.3M in gross proceeds ($0.725/share). Underwriters over-allotment is an additional $3M of stock. More news on: TransEnterix, Inc., Health...

TransEnterix, Inc. (NYSE American: TRXC) today announced that it priced a public offering of 28,000,000 shares of its common stock for gross proceeds of approximately $20.3 million, before deducting underwriting discounts and commissions and offering expenses payable by TransEnterix. In addit...

TransEnterix (NYSEMKT: TRXC ) is 9.4% lower postmarket after filing to offer shares of common stock . More news on: TransEnterix, Inc., Healthcare stocks news, Stocks on the move, Read more ...

TransEnterix, Inc. (NYSE American: TRXC) today announced that it has commenced an underwritten public offering of shares of its common stock. TransEnterix intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the publ...

TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Confere...

Our last article on TransEnterix ( TRXC ) titled: Last Quarter’s Results Proves That TransEnterix’ Surgical Robot Is A Total Failure , proved to be dead on accurate. In fact, you can make the argument that we weren’t bearish enough. After selling five surgical robots in...

Gainers : Corindus Vascular Robotics (NYSEMKT: CVRS ) +76% . Vitamin Shoppe (NYSE: VSI ) +41% . Avedro (NASDAQ: AVDR ) +36% . G1 Therapeutics (NASDAQ: GTHX ) +27% . Alpha and Omega Semiconductor (NASDAQ: AOSL ) +22% . Carvana (NYSE: CVNA ) +21% . Roku (NASDAQ: ROKU ) +20% ...